Matthew Rogell, MD
Orthopaedic Surgery · Danbury, CTNPI 1972690725
Payments from drug & device makers
Across 109 payments — averaging $65.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Stryker$1K
- Pacira Pharmaceuticals Incorporated$575
- Johnson & Johnson$431
- Hikma Pharmaceuticals USA$305
- Amgen$229
- plus $593 from 8 others
What the payments were for
- Consulting fees$3054%
- Travel & lodging$3,14244%
- Food & beverage$3,66552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $3,693 |
| Stryker | 10 | $1,287 |
| Pacira Pharmaceuticals Incorporated | 4 | $575 |
| Johnson & Johnson | 23 | $431 |
| Hikma Pharmaceuticals USA | 1 | $305 |
| Amgen | 22 | $229 |
| Pacira Therapeutics, Inc. | 3 | $162 |
| Cook Medical LLC | 1 | $145 |
| Bioventus LLC | 5 | $124 |
| Molnlycke Health Care US, LLC | 1 | $97 |
| Abbott | 1 | $24 |
| Vericel Corporation | 1 | $19 |
| Naviswiss, Inc. | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Navio Surgical System$1,507
- Journey II CR$1,251
- POLARSTEM$1,246
- MAKO$1,091
- Journey II XR$908
- VISIONAIRE Cutting Guides$811
- Iovera$494
- COMBOGESIC IV$305
- AETOS Shoulder System$294
- REDAPT Revision Hip System$267
- Legion Revision$267
- Anthology$263
- Cook$145
- REDAPT$144
- REAL INTELLIGENCE$144
- Legion$144
- Journey II$144
- Zilretta$123
How this compares
$7,113 in reported general payments places this provider in the 65th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 13 | $1,114 |
| Meloxicam | 220 | $734 |
| Oxycodone Hcl | 44 | $455 |
| Tramadol Hcl | 89 | $377 |
| Methylprednisolone | 34 | $286 |
| Cefadroxil | 44 | $273 |
| Mupirocin | 26 | $216 |
| Pantoprazole Sodium | 39 | $183 |
| Celecoxib | 23 | $183 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $141 |
| Hydroxyzine Pamoate | 19 | $49 |
| Amoxicillin | 27 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Danbury
- Robert DeveneyDanbury$907K
- Theodore WolfsonDanbury$86K
- Jacob ModestDanbury$43K
- Abiola AtandaDanbury$27K
- Peter WhangNew Haven$2M
- James YueShelton$1.8M
- Paul SethiGreenwich$1.6M
- Isaac MossFarmington$783K
- James PaceFarmington$721K
- John KeggiMiddlebury$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.